SPINE BIOPHARMA, INC.

Profile

Company Names

SPINE BIOPHARMA, INC.
SPINE BIOPHARMA, LLC

Addresses

505 PARK AVENUE, 14TH FLOOR, NEW YORK, NY 10022

Phone Numbers

212-583-9700

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS

Year Incorporated:

> 5 years ago

State Incorporated:

DELAWARE

Total Amount Raised:

$52,189,933.00

Number of Funding Rounds:

8
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
8
2026-05-22 
$384,798.00 
$8,500,000.00 
$8,115,202.00 
Equity 
7
2024-09-09 
$13,505,000.00 
$23,500,000.00 
$9,995,000.00 
Equity, Debt 
6
2023-10-04 
$2,399,629.00 
$15,000,000.00 
$12,600,371.00 
Equity, Debt 
5
2023-08-24 
$1,900,000.00 
$13,000,000.00 
$11,100,000.00 
Equity 
4
2023-02-03 
$13,000,000.00 
$13,000,000.00 
$0.00 
Debt 
3
2022-03-17 
$12,999,991.00 
$30,350,000.00 
$17,350,009.00 
Equity 
2
2021-04-16 
$3,000,000.00 
$3,000,000.00 
$0.00 
Equity, Debt 
1
2021-03-12 
$5,000,515.00 
$5,000,515.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
THOMAS 
 
BUMOL, PHD 
DIRECTOR
FRANK 
 
CAMMISA, MD 
DIRECTOR
JASON 
 
GALLAGHER 
EXECUTIVE OFFICER
FRAN 
 
MAGEE 
EXECUTIVE OFFICER
JOHN 
VISCOGLIOSI 
EXECUTIVE OFFICER
LLC 
 
VISCOGLIOSI BROTHERS, 
EXECUTIVE OFFICER
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2026-05-22 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2024-09-09 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2023-10-04 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2023-08-24 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2023-02-03 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2022-03-17 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2021-04-16 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2021-03-12 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#